 |
ataluren |
|---|---|
| Trade Name | |
| Orphan Indication | Muscular Dystrophy resulting from premature stop mutations in the dystrohin gene |
| USA Market Approval | USA |
| USA Designation Date | 2005-01-10 00:00:00 |
| Sponsor | PTC Therapeutics, Inc.;100 Corporate Court;South Plainfield, New Jersey, 07080 |
